Maryland Venture Fund, established in 1994 and based in Columbia, Maryland, is an early-stage venture capital firm with a focus on nurturing innovative companies within the state. With a capital base of $110 million, the Fund engages in both direct investments in technology and life sciences, as well as indirect investments in venture capital funds. It typically invests between $0.1 million and $1 million in companies that generate revenues up to $1 million, primarily targeting businesses with fewer than 50 employees that have been operational for no more than five years. The Fund specializes in sectors such as healthcare technology, cybersecurity, and information technology. Investments are structured as equity or convertible debt, and the firm seeks to support companies certified as qualified Maryland cybersecurity entities by the state’s Department of Business and Economic Development.
BrainScope Company develops non-invasive medical devices to aid professionals in assessing traumatic brain injuries. Its flagship product, BrainScope One, uses electroencephalogram signals and advanced algorithms to objectively determine the likelihood of concussion presence and severity. Serving military markets, emergency departments, and sports sectors worldwide.
BrainScope Company
Grant in 2014
BrainScope Company develops non-invasive medical devices to aid professionals in assessing traumatic brain injuries. Its flagship product, BrainScope One, uses electroencephalogram signals and advanced algorithms to objectively determine the likelihood of concussion presence and severity. Serving military markets, emergency departments, and sports sectors worldwide.
BrainScope Company
Convertible Note in 2013
BrainScope Company develops non-invasive medical devices to aid professionals in assessing traumatic brain injuries. Its flagship product, BrainScope One, uses electroencephalogram signals and advanced algorithms to objectively determine the likelihood of concussion presence and severity. Serving military markets, emergency departments, and sports sectors worldwide.
BrainScope Company
Series A in 2012
BrainScope Company develops non-invasive medical devices to aid professionals in assessing traumatic brain injuries. Its flagship product, BrainScope One, uses electroencephalogram signals and advanced algorithms to objectively determine the likelihood of concussion presence and severity. Serving military markets, emergency departments, and sports sectors worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.